Vertex Pharmaceuticals
VRTX
#130
Rank
$115.05 B
Marketcap
$445.87
Share price
0.15%
Change (1 day)
31.15%
Change (1 year)

P/S ratio for Vertex Pharmaceuticals (VRTX)

P/S ratio as of May 2024 (TTM): 11.7

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.6583. At the end of 2023 the company had a P/S ratio of 10.6.

P/S ratio history for Vertex Pharmaceuticals from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
202310.627.99%
20228.3012.49%
20217.38-25.49%
20209.90-27.3%
201913.6-1.82%
201813.9-8.89%
201715.241.87%
201610.7-64.24%
201530.0-39.33%
201449.5245.26%
201314.3140.39%
20125.9621.42%
20114.91-90.13%
201049.7-40.87%
200984.1243.25%
200824.557.95%
200715.5-28.9%
200621.817.27%
200518.6123.8%
20048.31-31.45%
200312.161.36%
20027.51-46.1%
200113.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.15-64.39%๐Ÿ‡บ๐Ÿ‡ธ USA
5.41-53.59%๐Ÿ‡บ๐Ÿ‡ธ USA
3.12-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
5.53-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
1.96-83.19%๐Ÿ‡บ๐Ÿ‡ธ USA
3.59-69.23%๐Ÿ‡บ๐Ÿ‡ธ USA